Public health departments across the United States will test generative AI tools under a new program involving the Coalition for Health AI (CHAI), OpenAI, Anthropic, and Accenture.
According to Artificial Intelligence News, the program is called the Public Health Use Case and Learning Scaling Engine, or PULSE. It will support trials in 10 state, local, tribal, or territorial jurisdictions across the country.
What the PULSE Program Offers Public Health Agencies
The program is designed to give public health practitioners access to enterprise AI products from OpenAI and Anthropic. The goal is to test how these generative AI tools can be used in real-world public health settings.
OpenAI and Anthropic have donated 10 enterprise licenses with capacity for up to 2,000 public health practitioners, as reported by Artificial Intelligence News. This means a significant number of health workers will be able to use the AI tools during the trial period.
Accenture's Role and Program Goals
Accenture, the global professional services company, will oversee participant onboarding. The company will also help develop playbooks based on the trials. These playbooks are intended to serve as implementation guidance for other public health agencies that may consider similar AI deployments in the future.
The program is expected to produce clear, practical guidance for public health agencies. This is important because many health departments are interested in using AI but lack the experience or resources to test it safely.
Our Take: A Practical Step for AI in Public Health
This program is a sensible approach to testing AI in public health. Instead of rushing into large-scale deployments, the PULSE program allows for controlled trials in 10 jurisdictions. The involvement of CHAI, a coalition focused on health AI standards, adds credibility.
In our view, the key here is the focus on producing implementation guidance. Many public health agencies want to use AI but do not know where to start. By creating playbooks based on real trials, this program could help bridge that gap. The donation of enterprise licenses by OpenAI and Anthropic also removes a major cost barrier for participating agencies.
However, the success of this program will depend on transparency. The public will want to know how these AI models perform, what data they use, and whether they produce reliable results. If the program shares its findings openly, it could set a strong example for how AI can be responsibly integrated into public health work.
